| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |